{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:41:01Z","timestamp":1787020861876,"version":"build-2736575974"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,10,8]],"date-time":"2024-10-08T00:00:00Z","timestamp":1728345600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,10,8]],"date-time":"2024-10-08T00:00:00Z","timestamp":1728345600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["No. 92068108"],"award-info":[{"award-number":["No. 92068108"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["No. 82370072"],"award-info":[{"award-number":["No. 82370072"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["No. 32370851"],"award-info":[{"award-number":["No. 32370851"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program","doi-asserted-by":"crossref","award":["2023YFC3605100"],"award-info":[{"award-number":["2023YFC3605100"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program","doi-asserted-by":"crossref","award":["2020YFA0804000"],"award-info":[{"award-number":["2020YFA0804000"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program","doi-asserted-by":"crossref","award":["2021YFA1101600"],"award-info":[{"award-number":["2021YFA1101600"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"crossref"}]},{"name":"the international cooperation project of China Manned Space Program, the International Partnership Program of Chinese Academy of Sciences","award":["No. 152111KYSB20160004"],"award-info":[{"award-number":["No. 152111KYSB20160004"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Stem Cell Res Ther"],"DOI":"10.1186\/s13287-024-03945-4","type":"journal-article","created":{"date-parts":[[2024,10,8]],"date-time":"2024-10-08T12:02:11Z","timestamp":1728388931000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Optimized administration of human embryonic stem cell-derived immunity-and-matrix regulatory cells for mouse lung injury and fibrosis"],"prefix":"10.1186","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7723-7503","authenticated-orcid":false,"given":"Dingyun","family":"Song","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongwen","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faguo","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaiwei","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaidi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"An","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zai","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiemei","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huaiyong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lixin","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huaping","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,10,8]]},"reference":[{"key":"3945_CR1","doi-asserted-by":"publisher","first-page":"101987","DOI":"10.1016\/j.pupt.2020.101987","volume":"66","author":"M Mura","year":"2020","unstructured":"Mura M. Use of nintedanib in interstitial lung disease other than idiopathic pulmonary fibrosis: much caution is warranted. Pulm Pharmacol Ther. 2020;66:101987.","journal-title":"Pulm Pharmacol Ther"},{"issue":"12","key":"3945_CR2","doi-asserted-by":"publisher","first-page":"2277","DOI":"10.1016\/j.drudis.2020.09.019","volume":"25","author":"S Cruwys","year":"2020","unstructured":"Cruwys S, et al. Drug discovery and development in idiopathic pulmonary fibrosis: challenges and opportunities. Drug Discove Today. 2020;25(12):2277\u201383.","journal-title":"Drug Discove Today"},{"issue":"5","key":"3945_CR3","doi-asserted-by":"publisher","first-page":"2031","DOI":"10.1007\/s00018-020-03693-7","volume":"78","author":"THG Phan","year":"2021","unstructured":"Phan THG, et al. Emerging cellular and molecular determinants of idiopathic pulmonary fibrosis. Cell and Mole Life Sci. 2021;78(5):2031\u201357. https:\/\/doi.org\/10.1007\/s00018-020-03693-7.","journal-title":"Cell and Mole Life Sci"},{"issue":"9","key":"3945_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41422-020-0354-1","volume":"30","author":"J Wu","year":"2020","unstructured":"Wu J, et al. Immunity-and-matrix-regulatory cells derived from human embryonic stem cells safely and effectively treat mouse lung injury and fibrosis. Cell Res. 2020;30(9):1\u201316.","journal-title":"Cell Res"},{"key":"3945_CR5","unstructured":"First case of COVID\u201019 infused with hESC derived immunity\u2010 and matrix\u2010regulatory cells. Cell Proliferation, 2020"},{"key":"3945_CR6","doi-asserted-by":"publisher","DOI":"10.1111\/cpr.12944","author":"J Wu","year":"2020","unstructured":"Wu J, et al. Phase 1 trial for treatment of COVID-19 patients with pulmonary fibrosis using hESC-IMRCs. Cell Prolif. 2020. https:\/\/doi.org\/10.1111\/cpr.12944.","journal-title":"Cell Prolif"},{"key":"3945_CR7","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/j.stemcr.2017.04.017","volume":"9","author":"G Qi","year":"2017","unstructured":"Qi G, et al. Accreditation of biosafe clinical-grade human embryonic stem cells according to Chinese regulations. Stem Cell Reports. 2017;9:366\u201380.","journal-title":"Stem Cell Reports"},{"issue":"4","key":"3945_CR8","first-page":"893","volume":"120","author":"SV Szapiel","year":"1979","unstructured":"Szapiel SV, et al. Bleomycin-induced interstitial pulmonary disease in the nude, athymic mouse. Am Rev Respir Dis. 1979;120(4):893.","journal-title":"Am Rev Respir Dis"},{"issue":"7769","key":"3945_CR9","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1038\/s41586-019-1456-0","volume":"572","author":"AA Barkal","year":"2019","unstructured":"Barkal AA, et al. CD24 signalling through macrophage Siglec-10 is a target for cancer immunotherapy. Nature. 2019;572(7769):392\u20136.","journal-title":"Nature."},{"issue":"9","key":"3945_CR10","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1038\/s41422-020-0354-1","volume":"30","author":"J Wu","year":"2020","unstructured":"Wu J, et al. Immunity-and-matrix-regulatory cells derived from human embryonic stem cells safely and effectively treat mouse lung injury and fibrosis. Cell Res. 2020;30(9):794\u2013809.","journal-title":"Cell Res"},{"issue":"5","key":"3945_CR11","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1111\/resp.12093","volume":"18","author":"YG Zhu","year":"2013","unstructured":"Zhu YG, et al. Adult stem cells for acute lung injury: remaining questions and concerns. Respirology. 2013;18(5):744\u201356.","journal-title":"Respirology"},{"issue":"9","key":"3945_CR12","doi-asserted-by":"publisher","first-page":"1466","DOI":"10.1016\/j.exphem.2007.05.012","volume":"35","author":"X Yan","year":"2007","unstructured":"Yan X, et al. Injured microenvironment directly guides the differentiation of engrafted Flk-1+ mesenchymal stem cell in lung. Exp Hematol. 2007;35(9):1466\u201375.","journal-title":"Exp Hematol"},{"issue":"6","key":"3945_CR13","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1136\/thoraxjnl-2011-201059","volume":"67","author":"GF Curley","year":"2012","unstructured":"Curley GF, Hayes M, Ansari B, Shaw G, Ryan A, Barry F, O\u2019Brien T, O\u2019Toole D, Laffey JG. Mesenchymal stem cells enhance recovery and repair following ventilator-induced lung injury in the rat. Thorax. 2012;67(6):496\u2013501. https:\/\/doi.org\/10.1136\/thoraxjnl-2011-201059.","journal-title":"Thorax"},{"issue":"3","key":"3945_CR14","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1016\/j.ajpath.2011.05.027","volume":"179","author":"S Saito","year":"2011","unstructured":"Saito S, et al. Mesenchymal stem cells stably transduced with a dominant-negative inhibitor of CCL2 greatly attenuate bleomycin-induced lung damage. Am J Pathol. 2011;179(3):1088\u201394.","journal-title":"Am J Pathol"},{"issue":"1","key":"3945_CR15","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s12931-018-0730-2","volume":"19","author":"G Sgalla","year":"2018","unstructured":"Sgalla G, et al. Idiopathic pulmonary fibrosis: pathogenesis and management. Respir Res. 2018;19(1):32.","journal-title":"Respir Res"},{"issue":"1","key":"3945_CR16","doi-asserted-by":"publisher","first-page":"2","DOI":"10.3390\/jcm6010002","volume":"6","author":"A Betensley","year":"2017","unstructured":"Betensley A, Sharif R, Karamichos D. A systematic review of the role of dysfunctional wound healing in the pathogenesis and treatment of idiopathic pulmonary fibrosis. J Clin Med. 2017;6(1):2.","journal-title":"J Clin Med"},{"issue":"14","key":"3945_CR17","doi-asserted-by":"publisher","first-page":"8407","DOI":"10.1073\/pnas.1432929100","volume":"100","author":"LA Ortiz","year":"2003","unstructured":"Ortiz LA, et al. Mesenchymal stem cell engraftment in lung is enhanced in response to bleomycin exposure and ameliorates its fibrotic effects. Proc Natl Acad Sci. 2003;100(14):8407\u201311.","journal-title":"Proc Natl Acad Sci"},{"key":"3945_CR18","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1002\/jcp.24436","volume":"229","author":"Z Sun","year":"2014","unstructured":"Sun Z, et al. Inhibition of Wnt\/\u03b2-Catenin signaling promotes engraftment of mesenchymal stem cells to repair lung injury. J Cell Phys. 2014;229:213.","journal-title":"J Cell Phys"},{"key":"3945_CR19","unstructured":"Wang, et al., Bone marrow mesenchymal stem cells attenuate silica-induced pulmonary fibrosis via paracrine mechanisms. Toxicology Letters An International Journal Providing A Forum for Original & Pertinent Contributions in Toxicology Research, 2017"},{"issue":"4","key":"3945_CR20","doi-asserted-by":"publisher","first-page":"2831","DOI":"10.3892\/mmr.2014.3092","volume":"11","author":"Q Shen","year":"2015","unstructured":"Shen Q, et al. Paracrine factors from mesenchymal stem cells attenuate epithelial injury and lung fibrosis. Mol Med Rep. 2015;11(4):2831.","journal-title":"Mol Med Rep"},{"issue":"3","key":"3945_CR21","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/j.cell.2013.01.011","volume":"152","author":"W Chen","year":"2013","unstructured":"Chen W, et al. Induction of siglec-G by RNA viruses inhibits the innate immune response by promoting RIG-I degradation. Cell. 2013;152(3):467\u201378.","journal-title":"Cell"},{"issue":"5","key":"3945_CR22","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1038\/nbt.1846","volume":"29","author":"GY Chen","year":"2011","unstructured":"Chen GY, et al. Amelioration of sepsis by inhibiting sialidase-mediated disruption of the CD24-SiglecG interaction. Nat Biotechnol. 2011;29(5):428.","journal-title":"Nat Biotechnol"},{"key":"3945_CR23","unstructured":"Guo-Yun, et al., CD24 and Siglec-10 Selectively Repress Tissue Damage-Induced Immune Responses. Science, 2009"},{"issue":"6","key":"3945_CR24","doi-asserted-by":"publisher","first-page":"1901105","DOI":"10.1183\/13993003.01105-2019","volume":"55","author":"P Kolb","year":"2020","unstructured":"Kolb P, et al. The importance of interventional timing in the bleomycin model of pulmonary fibrosis. Eur Respir J. 2020;55(6):1901105.","journal-title":"Eur Respir J"},{"issue":"2","key":"3945_CR25","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1164\/rccm.201302-0351ED","volume":"188","author":"DJ Weiss","year":"2013","unstructured":"Weiss DJ, Ortiz LA. Cell therapy trials for lung diseases: progress and cautions. Am J Respir Crit Care Med. 2013;188(2):123\u20135.","journal-title":"Am J Respir Crit Care Med"}],"container-title":["Stem Cell Research & Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-024-03945-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13287-024-03945-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-024-03945-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,8]],"date-time":"2024-10-08T12:12:37Z","timestamp":1728389557000},"score":1,"resource":{"primary":{"URL":"https:\/\/stemcellres.biomedcentral.com\/articles\/10.1186\/s13287-024-03945-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,8]]},"references-count":25,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["3945"],"URL":"https:\/\/doi.org\/10.1186\/s13287-024-03945-4","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-4137809\/v1","asserted-by":"object"}]},"ISSN":["1757-6512"],"issn-type":[{"value":"1757-6512","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,8]]},"assertion":[{"value":"27 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 September 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 October 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"For animal experiments, the study entitled \u201cTherapeutic effect of human embryonic stem cell derived mesenchymal stem cells on bleomycin induced pulmonary fibrosis in mice\u201d was approved by the Experimental Animal Ethics Committee of China-Japan Friendship Hospital (Date: 27. 02. 2019, No.190108) and performed according to the Beijing Laboratory Animal Management Ordinance, guidelines. Our study involves IMRCs lines, therefore ethics approval is not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"344"}}